Literature DB >> 18710292

Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design.

Luis Eduardo Rodriguez1, Hernando Curtidor, Mauricio Urquiza, Gladys Cifuentes, Claudia Reyes, Manuel Elkin Patarroyo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710292     DOI: 10.1021/cr068407v

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  33 in total

1.  Crystallographic studies of the coupling segment NBD94(674-781) of the nucleotide-binding domain of the Plasmodium yoelii reticulocyte-binding protein Py235.

Authors:  Ardina Grüber; Malathy S S Manimekalai; Peter R Preiser; Gerhard Grüber
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-11-26

2.  Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.

Authors:  Kazutoyo Miura; Hong Zhou; Ababacar Diouf; Samuel E Moretz; Michael P Fay; Louis H Miller; Laura B Martin; Mark A Pierce; Ruth D Ellis; Gregory E D Mullen; Carole A Long
Journal:  Clin Vaccine Immunol       Date:  2009-05-13

3.  Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro.

Authors:  Marisol Ocampo; Hernando Curtidor; Magnolia Vanegas; Manuel A Patarroyo; Manuel E Patarroyo
Journal:  Chem Biol Drug Des       Date:  2014-07-10       Impact factor: 2.817

4.  The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites.

Authors:  Benjamin L Rice; Mónica M Acosta; M Andreína Pacheco; Jane M Carlton; John W Barnwell; Ananias A Escalante
Journal:  Mol Phylogenet Evol       Date:  2014-05-23       Impact factor: 4.286

5.  Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax.

Authors:  Bo Wang; Feng Lu; Yang Cheng; Jian Li; Daisuke Ito; Jetsumon Sattabongkot; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2012-10-25       Impact factor: 2.289

6.  The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species.

Authors:  Stella M Chenet; M Andreína Pacheco; David J Bacon; William E Collins; John W Barnwell; Ananias A Escalante
Journal:  Infect Genet Evol       Date:  2013-09-14       Impact factor: 3.342

7.  3D analysis of the TCR/pMHCII complex formation in monkeys vaccinated with the first peptide inducing sterilizing immunity against human malaria.

Authors:  Manuel A Patarroyo; Adriana Bermúdez; Carolina López; Gloria Yepes; Manuel E Patarroyo
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

8.  Structural determination of functional units of the nucleotide binding domain (NBD94) of the reticulocyte binding protein Py235 of Plasmodium yoelii.

Authors:  Ardina Grüber; Malathy S S Manimekalai; Asha M Balakrishna; Cornelia Hunke; Jeyaraman Jeyakanthan; Peter R Preiser; Gerhard Grüber
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

9.  Fine mapping of Plasmodium falciparum ribosomal phosphoprotein PfP0 revealed sequences with highly specific binding activity to human red blood cells.

Authors:  Gabriela Arevalo-Pinzon; Hernando Curtidor; Claudia Reyes; Martha Pinto; Carolina Vizcaíno; Manuel A Patarroyo; Manuel E Patarroyo
Journal:  J Mol Med (Berl)       Date:  2009-09-21       Impact factor: 4.599

10.  Variations in the electrostatic landscape of class II human leukocyte antigen molecule induced by modifications in the myelin basic protein peptide: a theoretical approach.

Authors:  William A Agudelo; Johan F Galindo; Marysol Ortiz; José L Villaveces; Edgar E Daza; Manuel E Patarroyo
Journal:  PLoS One       Date:  2009-01-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.